Names, Routes, and Classes Flashcards
1
Q
Dasatinib
A
[SPRYCEL]
P.O.
TKI for BCR-ABL1 (Ph+) CML, sometimes Acute Leukemias (that are also Ph+)
2
Q
Denosumab
A
[PROLIA, XGEVA]
S.Q.
mAb (RANK ligand inhibitor)
Prevents bone loss/hyperCa++ for bone lesions.
3
Q
Bortezomib
A
[VELCADE]
I.V. or S.Q.
Proteasome Inhibitor
1st+ for MM, 2nd+ for MCL
4
Q
Ibrutinib
A
[IMBRUVICA]
P.O.
BTK inhibitor
CLL/SLL, esp. with del(17p); WM; 2nd line MZL; cGVHD.
5
Q
Zanubrutinib
A
[BRUKINSA]
P.O.
BTK inhibitor
2nd line MCL and MZL; WM; CLL/SLL